Elevated Levels of Lactate Dehydrogenase Predicts Poor Outcomes for Patients with COVID-19: A Review

References (76)

1. 1 Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [DOI]
2. 2 Clinical Characteristics of Coronavirus Disease 2019 in China [DOI]
3. 3 Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study [DOI]
4. 4 Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study [DOI]
5. 5 Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China [DOI]
6. 6 Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia [DOI]
7. 7 Presumed Asymptomatic Carrier Transmission of COVID-19 [DOI]
8. 8 A Prediction Rule to Identify Low-Risk Patients with Community-Acquired Pneumonia [DOI]
9. 9 Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient [DOI]
10. 10 The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease [DOI]
11. 11 Clinical Characteristics of Refractory Coronavirus Disease 2019 in Wuhan, China [DOI]
12. 12 Hematologic parameters in patients with COVID‐19 infection [DOI]
13. 13 Lactate dehydrogenase A: A key player in carcinogenesis and potential target in cancer therapy [DOI]
14. 14 Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS‐CoV‐2 [DOI]
15. 15 Comprehensive review on lactate metabolism in human health [DOI]
16. 16 C‐reactive protein correlates with computed tomographic findings and predicts severe COVID‐19 early [DOI]
17. 17 The Regulation and Function of Lactate Dehydrogenase A: Therapeutic Potential in Brain Tumor [DOI]
18. 18 Clinical and High-Resolution CT Features of the COVID-19 Infection: Comparison of the Initial and Follow-up Changes [DOI]
19. 19 Outcomes and Prognostic Factors in 267 Patients with Severe Acute Respiratory Syndrome in Hong Kong [DOI]
20. 20 Ketones and lactate increase cancer cell “stemness,” driving recurrence, metastasis and poor clinical outcome in breast cancer [DOI]
21. 21 Structural basis for altered activity of M‐ and H‐isozyme forms of human lactate dehydrogenase [DOI]
22. 22 The Actual Role of LDH as Tumor Marker, Biochemical and Clinical Aspects [DOI]
23. 23 CT manifestations of coronavirus disease-2019: A retrospective analysis of 73 cases by disease severity [DOI]
24. 24 Lactate Dehydrogenases as Metabolic Links between Tumor and Stroma in the Tumor Microenvironment [DOI]
25. 25 Death After Graft Loss: An Important Late Study Endpoint in Kidney Transplantation [DOI]
26. 26 Inhibitors of Lactate Dehydrogenase Isoforms and their Therapeutic Potentials [DOI]
27. 27 Lactate dehydrogenase: a marker of diminished antitumor immunity [DOI]
28. 28 The correlation between viral clearance and biochemical outcomes of 94 COVID-19 infected discharged patients [DOI]
29. 29 An enzymatic approach to lactate production in human skeletal muscle during exercise [DOI]
30. 30 CT features of SARS-CoV-2 pneumonia according to clinical presentation: a retrospective analysis of 120 consecutive patients from Wuhan city [DOI]
31. 31 Aberrant FGFR Tyrosine Kinase Signaling Enhances the Warburg Effect by Reprogramming LDH Isoform Expression and Activity in Prostate Cancer [DOI]
32. 32 Hospitalized adult patients with 2009 influenza A(H1N1) in Beijing, China: risk factors for hospital mortality [DOI]
33. 33 Hypoxia and exercise provoke both lactate release and lactate oxidation by the human brain [DOI]
34. 34 Identification of human D lactate dehydrogenase deficiency [DOI]
35. 35 Acute myocardial infarction in thrombotic microangiopathies—clinical characteristics, risk factors and outcome [DOI]
36. 36 Lactate dehydrogenase predicts hypoxic ischaemic encephalopathy in newborn infants: a preliminary study [DOI]
37. 37 Computational analyses of mammalian lactate dehydrogenases: Human, mouse, opossum and platypus LDHs [DOI]
38. 38 Serum lactate dehydrogenase is predictive of persistent organ failure in acute pancreatitis [DOI]
39. 39 Viral infection in community acquired pneumonia patients with fever: a prospective observational study [DOI]
40. 40 Inhibition of lactate dehydrogenase A suppresses inflammatory response in RAW 264.7 macrophages [DOI]
41. 41 Use of LDH and Autoimmune Side Effects to Predict Response to Ipilimumab Treatment [DOI]
42. 42 l-Lactate Transport and Metabolism in Mitochondria of Hep G2 Cells—The Cori Cycle Revisited [DOI]
43. 43 Prognostic Value of Lactate Dehydrogenase for Mid-Term Mortality in Acute Decompensated Heart Failure: A Comparison to Established Biomarkers and Brain Natriuretic Peptide [DOI]
44. 44 LDH Concentration in Nasal-Wash Fluid as a Biochemical Predictor of Bronchiolitis Severity [DOI]
45. 45 Human Lactate Dehydrogenase A Inhibitors: A Molecular Dynamics Investigation [DOI]
46. 46 Serum Lactate Dehydrogenase in Interstitial Lung Disease [DOI]
47. 47 Lung Metabolism and Inflammation during Mechanical Ventilation; An Imaging Approach [DOI]
48. 48 Physical therapy–induced rhabdomyolysis and acute kidney injury associated with reduced activity of muscle lactate dehydrogenase A [DOI]
49. 49 An Imperative Need for Research on the Role of Environmental Factors in Transmission of Novel Coronavirus (COVID-19) [DOI]
50. 50 Lactate dehydrogenase, a Risk Factor of Severe COVID-19 Patients: A Retrospective and Observational Study [DOI]
51. 51 Home visits: a strategy to improve newborn survival - Authors' reply [DOI]
52. 52 Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan [DOI]
53. 53 COVID-19 pathophysiology: A review [DOI]
54. 54 Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis [DOI]
55. 55 Coronavirus disease 2019 (COVID-19): A literature review [DOI]
56. 56 The role of biomarkers in diagnosis of COVID-19 – A systematic review [DOI]
57. 57 Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis [DOI]
58. 58 Analysis of SARS-CoV-2 vertical transmission during pregnancy [DOI]
59. 59 COVID‐19 and the clinical hematology laboratory [DOI]
60. 60 Routine blood tests as a potential diagnostic tool for COVID-19 [DOI]
61. 61 Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients [DOI]
62. 62 Laboratory findings of COVID-19: a systematic review and meta-analysis [DOI]
63. 63 Decoding the evolution and transmissions of the novel pneumonia coronavirus (SARS-CoV-2 / HCoV-19) using whole genomic data [DOI]
64. 64 Elevated Lactate Dehydrogenase (LDH) level as an independent risk factor for the severity and mortality of COVID-19 [DOI]
65. 65 Multi-organ Dysfunction in Patients with COVID-19: A Systematic Review and Meta-analysis [DOI]
66. 66 SARS‐CoV‐2: A comprehensive review from pathogenicity of the virus to clinical consequences [DOI]
67. 67 Lactate dehydrogenase and susceptibility to deterioration of mild COVID-19 patients: a multicenter nested case-control study [DOI]
68. 68 Preventing COVID-19 in low- and middle-income countries [DOI]
69. 69 Prognostic value of lactate dehydrogenase for in-hospital mortality in severe and critically ill patients with COVID-19 [DOI]
70. 70 Clinical characteristics and prognosis of community-acquired pneumonia in autoimmune disease-induced immunocompromised host: A retrospective observational study [DOI]
71. 71 Accurate Results in the Clinical Laboratory [DOI]
72. 72 Biochemistry, Lactate Dehydrogenase (LDH)
73. 73 Different Modes of Transmission and Containment Strategies for COVID-19 [DOI]
74. 74 La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
75. 75 Clinical findings of 35 cases with novel coronavirus pneumonia outside of Wuhan [DOI]
76. 76 Prolonged viability of SARS-CoV-2 in fomites [DOI]

Cited by 1

Related research

• COVID 19 Disease Caused by Coronavirus 2 (SARS-CoV-2) (Severe Acute Respiratory Syndrome) — shares topic coverage
• Assessment of Anxiety in Healthcare Providers Working in ICU during COVID-19 Pandemics — shares topic coverage
• Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19 — shares topic coverage
• Addressing the Challenges of Containing Covid-19 Spread in a Rural, Poor Area in India: A Case Study — shares topic coverage
• COVID-19-Related Mortality across the Gulf Cooperation Council Countries: Based on Countries’ Available Data Up to November, 2020 — shares topic coverage